Amgen Reveals First Figures For US Humira Rival

Q1 Sales Disclosed For Amjevita Biosimilar As Brand Loses A Quarter Of Value In US

 
• By David Wallace
  
Amgen logo syringe vials
Amgen has published Q1 financial results for its US Humira biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business